RA Capital Management »

Genedx Holdings Corp shares owned by RA Capital Management

Quarter-by-quarter ownership of Genedx Holdings Corp (WGS) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Genedx Holdings Corp

Tip: Access up to 7 years of quarterly data

All positions including Genedx Holdings Corp held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genedx Holdings Corp by RA Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.3M 58k 107.74
2025-06-30 $5.4M 58k 92.31

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Rhythm Pharmaceuticals SH (RYTM)
Vaxcyte SH (PCVX)
Avidity Biosciences SH (RNA)
Cidara Therapeutics SH (CDTX)
Sionna Therapeutics SH (SION)
89bio SH (ETNB)
Newamsterdam Pharma Co Nv SH (NAMS)
Mineralys Therapeutics SH (MLYS)
Janux Therapeutics SH (JANX)
Arcellx SH (ACLX)
Lenz Therapeutics SH (LENZ)
Tyra Biosciences SH (TYRA)
Edgewise Therapeutics SH (EWTX)
Wave Life Sciences SH (WVE)

View all positions for RA Capital Management

Top funds holding Genedx Holdings Corp

Corvex Management
Casdin Capital
BlackRock
William Blair Investment Management
Vanguard Group
Goldman Sachs Group
Summit Partners Public Asset Management
Susquehanna International
Oracle Investment Management
Pentwater Capital Management
T. Rowe Price Investment Management
Franklin Resources
Zweig-DiMenna Associates
Jennison Associates
Westfield Capital Management Company

View all funds holding Genedx Holdings Corp